IRMD
Income statement / Annual
Last year (2023), IRadimed Corporation's total revenue was $65.56 M,
an increase of 23.00% from the previous year.
In 2023, IRadimed Corporation's net income was $17.19 M.
See IRadimed Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$65.56 M
|
$53.30 M
|
$41.81 M
|
$31.72 M
|
$38.52 M
|
$30.44 M
|
$23.08 M
|
$32.50 M
|
$31.59 M
|
$15.65 M
|
| Cost of Revenue |
$15.40 M |
$12.02 M |
$9.76 M |
$8.14 M |
$8.82 M |
$7.21 M |
$5.57 M |
$6.15 M |
$5.84 M |
$3.40 M |
| Gross Profit |
$50.16 M |
$41.28 M |
$32.05 M |
$23.57 M |
$29.70 M |
$23.23 M |
$17.51 M |
$26.34 M |
$25.75 M |
$12.25 M |
| Gross Profit Ratio |
0.77 |
0.77 |
0.77 |
0.74 |
0.77 |
0.76 |
0.76 |
0.81 |
0.82 |
0.78 |
| Research and Development
Expenses |
$2.86 M
|
$2.28 M
|
$1.91 M
|
$1.90 M
|
$1.43 M
|
$1.52 M
|
$1.72 M
|
$1.35 M
|
$1.76 M
|
$1.07 M
|
| General & Administrative
Expenses |
$15.12 M
|
$10.70 M
|
$9.77 M
|
$12.27 M
|
$10.45 M
|
$8.71 M
|
$9.00 M
|
$8.80 M
|
$7.77 M
|
$4.82 M
|
| Selling & Marketing
Expenses |
$12.14 M
|
$12.68 M
|
$10.56 M
|
$10.16 M
|
$9.17 M
|
$7.00 M
|
$5.50 M
|
$5.28 M
|
$4.71 M
|
$3.30 M
|
| Selling, General &
Administrative Expenses |
$27.26 M
|
$23.38 M
|
$20.33 M
|
$22.43 M
|
$19.62 M
|
$15.71 M
|
$14.50 M
|
$14.07 M
|
$12.48 M
|
$8.11 M
|
| Other Expenses |
$0.00 |
$553,104.00 |
$18,605.00 |
$139,213.00 |
$395,912.00 |
$193,537.00 |
$111,377.00 |
$32,680.00 |
$121,385.00 |
-$48,549.00 |
| Operating Expenses |
$30.12 M |
$25.65 M |
$22.23 M |
$24.33 M |
$21.05 M |
$17.22 M |
$16.23 M |
$15.42 M |
$14.24 M |
$9.18 M |
| Cost And Expenses |
$45.53 M |
$37.68 M |
$32.00 M |
$32.47 M |
$29.87 M |
$24.44 M |
$21.80 M |
$21.58 M |
$20.08 M |
$12.59 M |
| Interest Income |
$1.86 M |
$581,852.00 |
$34,806.00 |
$132,185.00 |
$388,801.00 |
$238,106.00 |
$122,575.00 |
$126,419.00 |
$148,907.00 |
$5,701.00 |
| Interest Expense |
$0.00 |
$581,852.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$765,180.00
|
$670,673.00
|
$634,010.00
|
$603,597.00
|
$591,181.00
|
$559,728.00
|
$445,271.00
|
$248,299.00
|
$223,942.00
|
$149,056.00
|
| EBITDA |
$20.80 M
|
$16.30 M
|
$11.22 M
|
$582,733.00
|
$9.89 M
|
$7.11 M
|
$2.59 M
|
$11.17 M
|
$11.51 M
|
$3.21 M
|
| EBITDA Ratio |
0.32 |
0.29 |
0.27 |
0.02 |
0.26 |
0.23 |
0.11 |
0.34 |
0.37 |
0.21 |
| Operating Income Ratio
|
0.31
|
0.29
|
0.23
|
-0.02
|
0.22
|
0.2
|
0.06
|
0.34
|
0.36
|
0.2
|
| Total Other
Income/Expenses Net |
$1.70 M
|
$553,104.00
|
$18,605.00
|
$139,213.00
|
$395,912.00
|
$193,537.00
|
$111,377.00
|
$32,680.00
|
$121,385.00
|
-$48,549.00
|
| Income Before Tax |
$21.74 M |
$16.18 M |
$9.84 M |
-$616,878.00 |
$9.04 M |
$6.20 M |
$1.40 M |
$10.95 M |
$11.63 M |
$3.02 M |
| Income Before Tax Ratio
|
0.33
|
0.3
|
0.24
|
-0.02
|
0.23
|
0.2
|
0.06
|
0.34
|
0.37
|
0.19
|
| Income Tax Expense |
$4.55 M |
$3.35 M |
$510,816.00 |
-$1.99 M |
-$587,642.00 |
-$106,143.00 |
$896,622.00 |
$3.74 M |
$4.10 M |
$966,975.00 |
| Net Income |
$17.19 M |
$12.83 M |
$9.33 M |
$1.37 M |
$9.63 M |
$6.30 M |
$499,764.00 |
$7.21 M |
$7.53 M |
$2.05 M |
| Net Income Ratio |
0.26 |
0.24 |
0.22 |
0.04 |
0.25 |
0.21 |
0.02 |
0.22 |
0.24 |
0.13 |
| EPS |
1.36 |
1.02 |
0.76 |
0.11 |
0.85 |
0.52 |
0.05 |
0.67 |
0.68 |
0.23 |
| EPS Diluted |
1.35 |
1.02 |
0.74 |
0.11 |
0.78 |
0.52 |
0.04 |
0.6 |
0.6 |
0.2 |
| Weighted Average Shares
Out |
$12.60 M
|
$12.56 M
|
$12.35 M
|
$12.12 M
|
$11.28 M
|
$12.11 M
|
$10.64 M
|
$10.82 M
|
$11.00 M
|
$8.74 M
|
| Weighted Average Shares
Out Diluted |
$12.72 M
|
$12.64 M
|
$12.59 M
|
$12.44 M
|
$12.28 M
|
$12.11 M
|
$11.72 M
|
$11.99 M
|
$12.56 M
|
$10.22 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
